Loading investment pitches...
Equity Research Database
Institutional Investment Pitches
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore thousands of hedge fund pitches, high-conviction equity research memos, and portfolio manager commentary extracted from quarterly letters.
Explore professional investment ideas sourced from institutional letters, short theses, and premium research channels, distilled into concise summaries.
| Pitch Type | Author | Industry | Pitch Thesis & Key Summary | Bull/Bear | Action | ||
|---|---|---|---|---|---|---|---|
| Jan 30, 2026 | Fund Letter | Dmitry Khaykin, Deepon NagClearBridge Investments Large Cap Value | Roche Holding $RHHBY• NASDAQ | PharmaceuticalsPharmaceuticals | ClearBridge Investments Large Cap Value 2025 Q3 (RHHBY) The company reported positive Phase III data for giredestrant in breast cancer and fenebrutinib in multiple sclerosis, paving the way for new treatments with peak sales opportunities of potentially over $5 billion each. These two products... | BULL | View Pitch → |
| Jan 23, 2026 | Fund Letter | Sydney Van VierzenEdgePoint Global | Roche Holding $RHHBY• NASDAQ | PharmaceuticalsPharmaceuticals | EdgePoint Global 2025 Q4 (RHHBY) During the volatility in early 2025, EdgePoint doubled down on Roche after the shares sold off more than could be justified by any change in the underlying business. Roche continued to... | BULL | View Pitch → |
Join institutional and professional investors receiving our weekly analysis of hedge fund letters, market trends, and high-conviction ideas.
Zero Spam • High Alpha • Unsubscribe Anytime
Investment pitches and theses displayed on Buyside Digest are summaries of opinions expressed in publicly available investor letters, research reports, or other commentary. These summaries are generated for informational and research purposes only and do not constitute investment recommendations, financial advice, or an endorsement of any particular security or strategy by Buyside Digest. Users should conduct their own independent due diligence and consult with professional advisors before making any investment decisions.